TY  - GEN
AU  - Auvray,Marie
AU  - Auclin,Edouard
AU  - Barthelemy,Philippe
AU  - Bono,Petri
AU  - Kellokumpu-Lehtinen,Pirkko
AU  - Gross-Goupil,Marine
AU  - De Velasco,Guillermo
AU  - Powles,Thomas
AU  - Mouillet,Guillaume
AU  - Vano,Yann-Alexandre
AU  - Gravis,Gwenaëlle
AU  - Mourey,Loïc
AU  - Priou,Franck
AU  - Rolland,Frédéric
AU  - Escudier,Bernard
AU  - Albiges,Laurence
TI  - Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
SN  - 1879-0852
PY  - 2020///0508
KW  - Adult
KW  - Aged
KW  - Anilides
KW  - therapeutic use
KW  - Antineoplastic Agents, Immunological
KW  - Axitinib
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - Ipilimumab
KW  - Kidney Neoplasms
KW  - pathology
KW  - Male
KW  - Middle Aged
KW  - Nivolumab
KW  - Progression-Free Survival
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Pyrimidines
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - antagonists & inhibitors
KW  - Sulfonamides
KW  - Sunitinib
KW  - Treatment Failure
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ejca.2018.11.031
ER  -